Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancerAjay Jain, Scott E. Strome, Erin Burch et al.|European Journal of Cancer|2013Cited by 7
Resistance of KRAS Mutant Colon Cancers to Cetuximab May Be Overcome Through Antibody EngineeringAjay Jain, Scott E. Strome, Bhawna Poonia et al.|Journal of Surgical Research|2012Cited by 0